Page last updated: 2024-08-24

gemcitabine and Fatty Liver, Nonalcoholic

gemcitabine has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castellanos, K; Cordoba-Chacon, J; Dawson, D; Dorman, MJ; Grimaldo, S; Grippo, PJ; Hirsch, E; Kumar, S; Mancinelli, G; McKinney, R; Munshi, HG; Principe, D; Rana, A; Torres, C; Viswakarma, N	1

Other Studies

1 other study(ies) available for gemcitabine and Fatty Liver, Nonalcoholic

Article	Year
p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 2019, 07-16, Volume: 116, Issue:29 Topics: Animals; Antimetabolites, Antineoplastic; Carcinogenesis; Carcinoma, Pancreatic Ductal; Class Ia Phosphatidylinositol 3-Kinase; Class Ib Phosphatidylinositol 3-Kinase; Deoxycytidine; Diet, High-Fat; Disease Models, Animal; Drug Resistance, Neoplasm; Fatty Acids, Omega-6; Female; Gemcitabine; Glucose; Humans; Lipid Metabolism; Liver; Male; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Obesity; Pancreas; Pancreatic Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Signal Transduction; Up-Regulation	2019

Article

Year

p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity.

Proceedings of the National Academy of Sciences of the United States of America, 2019, 07-16, Volume: 116, Issue:29

Topics: Animals; Antimetabolites, Antineoplastic; Carcinogenesis; Carcinoma, Pancreatic Ductal; Class Ia Phosphatidylinositol 3-Kinase; Class Ib Phosphatidylinositol 3-Kinase; Deoxycytidine; Diet, High-Fat; Disease Models, Animal; Drug Resistance, Neoplasm; Fatty Acids, Omega-6; Female; Gemcitabine; Glucose; Humans; Lipid Metabolism; Liver; Male; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Obesity; Pancreas; Pancreatic Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Signal Transduction; Up-Regulation

2019